The Marque Longevity Lab
- IV Therapy
- IV Hydration
- Hyperbaric Oxygen Therapy (HBOT)
- Oxygen Therapy
- Peptide Therapy
Virginia Beach, VA
Virginia Beach has a large Navy and Coast Guard population driving performance-medicine demand, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across the Oceanfront, Great Neck, and Hilltop range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Sentara, Chesapeake Regional, and the Portsmouth Naval Medical Center network. The scene here skews toward clinics serving active-duty SEALs, aviators, and Hampton Roads professionals. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Virginia Beach clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Regulatory context
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
The Virginia Board of Pharmacy inspects compounding pharmacies for USP compliance. Non-resident pharmacies shipping peptides into Virginia must hold a current non-resident permit. The Board publishes disciplinary actions. Virginia coordinates with DC and Maryland regulators for cross-border clinic operations.